WTO TRIPS Council discussions on the transparency of R&D costs and the pricing of medicines: The Good, The Bad, and The Ugly

In February 2020, the World Trade Organization (WTO) de-restricted the minutes of the TRIPS Council’s October 2019 session. While the official minutes (IP/C/M/93/Add.1) were circulated to WTO members on 9 December 2019, the October 2019 minutes were only available to… Continue Reading

Submission of Knowledge Ecology International on WIPO’s draft issues paper on Intellectual Property and Artificial Intelligence

On Friday, 14 February 2020, Knowledge Ecology International (KEI) submitted the following comments on a Draft Issues Paper on Intellectual Property Policy and Artificial Intelligence prepared by the World Intellectual Property Organization (WIPO). The Secretariat published this draft issues paper… Continue Reading

Submission of Knowledge Ecology International on the Draft General Comment: Science and economic, social and cultural rights Art. 15: 15.1b, 15.2, 15.3 and 15.4

On Friday, 14 February 2020, Knowledge Ecology International (KEI) submitted the following comments on the Draft General Comment on Science and economic, social and cultural rights prepared by the the Committee on Economic, Social and Cultural rights (CESCR). The draft… Continue Reading

WHO EB146: Statement of Knowledge Ecology International on WHO reform – Involvement of non-State actors in WHO’s governing bodies

On Saturday, 8 February 2020, Knowledge Ecology International (KEI) delivered the following statement on WHO reform – Involvement of non-State actors in WHO’s governing bodies at the 146th session of WHO’s Executive Board. Knowledge Ecology International Meeting: Executive Board 146… Continue Reading

WHO EB146: Statement of Knowledge Ecology International on the Global strategy and plan of action on public health, innovation and intellectual property

On Thursday evening, 6 February 2020, Knowledge Ecology International (KEI) delivered the following statement on WHO’s Global strategy and plan of action on public health, innovation and intellectual property. We request WHO’s Global Observatory on Health Research and Development to… Continue Reading

KEI Comments Regarding NIH Exclusive License to TeraImmune for T Cell Therapy

(UPDATE: The NIH provided a response to our comments on February 25, 2020) On February 3, 2020, Knowledge Ecology International (KEI) submitted comments to the “Prospective Grant of Exclusive Patent License: Development of Regulatory T-Cell Therapies for the Treatment of… Continue Reading